# Treatment of Peripheral T-cell Lymphoma

> **NCT01664975** · PHASE4 · COMPLETED · sponsor: **Mingzhi Zhang** · enrollment: 100 (actual)

## Conditions studied

- Peripheral T-cell Lymphoma

## Interventions

- **DRUG:** GDPT regimen
- **DRUG:** CHOP regimen

## Key facts

- **NCT ID:** NCT01664975
- **Lead sponsor:** Mingzhi Zhang
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2016-10-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01664975

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01664975, "Treatment of Peripheral T-cell Lymphoma". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT01664975. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*